Comparison Of Ultrasound-Based Measures Of Inferior Vena Cava And Internal Jugular Vein For Prediction Of Hypotension During Induction Of General Anesthesia

NCT ID: NCT05526625

Last Updated: 2022-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

133 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-01

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypotension after induction of general anesthesia is a frequent event in routine practice. Even a short period of hypotension may lead to tissue hypoperfusion and predispose to postoperative complications. Intra-operative hypotension is associated with renal injury, ischemic stroke, myocardial injury and postoperative mortality in patients having non-cardiac surgery under general anesthesia. Underlying hypovolemia is an important and modifiable risk factor for hypotension after anesthetics administration. Ultrasonographic studies of the inferior vena cava (IVC) and the internal jugular vein (IJV) for evaluation of intravascular volume status and prediction of hypotension during induction of general anesthesia have been established.

The present study was designed to compare, on ultrasound-based measures, between inferior vena cava and internal jugular vein for prediction of prolonged hypotension during induction of general anesthesia. The study was conducted at Kasr Al-Ainy hospital, Cairo University in Patients undergoing elective non-cardiac surgery under general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Upon arrival to the operating room, routine monitors in the form of pulse oximetry, electrocardiogarm and non-invasive blood pressure monitors were applied. Intravenous line was secured and routine premedications (ranitidine 50 mg and ondansetron 4 mg) were administered.

IVC evaluation was done for the patients in the supine position. The examination was performed after 5 minutes rest. A curved ultrasound transducer set to abdominal mode (1-5 MHz; Acuson x300; Siemens Healthcare, Seoul, Korea) was placed in the subcostal area to visualize the IVC in the paramedian long-axis view. The IVC was visualized using two-dimensional mode as it enters the right atrium; then, pulse wave doppler was used to differentiate the IVC from the aorta. Respiratory variations of the IVC diameter were evaluated using M-mode imaging at medium sweep speed 2 to 3 cm distal to the right atrium. The measures were obtained 3 times and their average was calculated. Maximum and minimum IVC diameters over a single respiratory cycle were used to calculate the collapsibility index as follows:

(dIVCmax- dIVCmin)/dIVCmax Collapsibility index was expressed as a percentage.

IJV measurements were obtained in the supine position using a linear ultrasound transducer (5 - 13 MHz; Acuson x300; Siemens Healthcare, Seoul, Korea). The probe was placed horizontally at the middle level of the thyroid cartilage. After obtaining a clear transverse view of the right IJV, the IJV area was measured. The measures were repeated after changing the patient's position to the 10° Trendelenburg position. The maximum area of the IJV in the supine and Trendelenburg positions was recorded and the rate of change in IJV area was calculated as follows:

IJV change rate with posture = (IJV area in Trendelenburg position - IJV area in supine position)/(IJV area in Trendelenburg position) All ultrasonographic measurements were performed by a single trained anesthesiologist.

IJV measurements were obtained in the supine position using a linear ultrasound transducer (5 - 13 MHz; Acuson x300; Siemens Healthcare, Seoul, Korea). The probe was placed horizontally at the middle level of the thyroid cartilage. After obtaining a clear transverse view of the right IJV, the IJV area was measured. The measures were repeated after changing the patient's position to the 10° Trendelenburg position. The maximum area of the IJV in the supine and Trendelenburg positions was recorded and the rate of change in IJV area was calculated as follows:

IJV change rate with posture = (IJV area in Trendelenburg position - IJV area in supine position)/(IJV area in Trendelenburg position) All ultrasonographic measurements were performed by a single trained anesthesiologist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ultrasound Based IVC IJV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound-based measurements of IVC & IJV.

Ultrasound-based measurements of IVC \& IJV.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 - 50 years old
* Any scheduled non-cardiac surgery under general anesthesia
* ASA I, II

Exclusion Criteria

* Patients with major vascular disease
* Unstable angina
* Ejection fraction \< 40 %
* Respiratory distress
* Increased intra-abdominal pressure.
* Diabetes mellitus
* Implanted pacemaker
* Patients on ACEI or ARB
* Anticipated difficult intubation
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ismail Fathy Ahmed Mohammed

M.Sc

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr Al-ainy hospital

Cairo, Cairo Government, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MD-13-2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Jugular Ultrasound for Spinal Hypotension
NCT07000188 ACTIVE_NOT_RECRUITING